Achmea Investment Management B.V. Moderna, Inc. Transaction History

Achmea Investment Management B.V.

$5.59 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $81,674 - $122,705	-1,175 Reduced 4.06%	27,763 $2.76 Million
Q3 2023 Nov 06, 2023	SELL	$96.41 - $126.61 $1.73 Million - $2.28 Million	-17,981 Reduced 38.32%	28,938 $2.99 Million
Q2 2023 Jul 24, 2023	BUY	$118.5 - $160.53 $1.41 Million - $1.91 Million	11,919 Added 34.05%	46,919 $5.7 Million
Q1 2023 May 04, 2023	BUY	$135.66 - $197.02 $215,699 - $313,261	1,590 Added 4.76%	35,000 $5.38 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $777,756 - $1.38 Million	-6,570 Reduced 16.43%	33,410 $5.62 Million
Q3 2022 Oct 27, 2022	SELL	$118.07 - $194.18 $2.09 Million - $3.43 Million	-17,664 Reduced 30.64%	39,980 $4.73 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $3.29 Million - $4.96 Million	-28,073 Reduced 32.75%	57,644 $8.23 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $10.8 Million - $20.1 Million	85,717 New	85,717 $14.8 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $11.1 Million - $18.1 Million	-49,235 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $5.87 Million - $12.8 Million	26,454 Added 116.12%	49,235 $18.9 Million
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $734,770 - $1.33 Million	5,656 Added 33.03%	22,781 $5.35 Million
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $76,535 - $130,371	701 Added 4.27%	17,125 $2.24 Million
Q4 2020 Feb 22, 2021	BUY	$65.74 - $169.86 $485,161 - $1.25 Million	7,380 Added 81.6%	16,424 $1.72 Million
Q3 2020 Nov 02, 2020	SELL	$54.34 - $94.85 $591,545 - $1.03 Million	-10,886 Reduced 54.62%	9,044 $640,000
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $591,323 - $1.59 Million	19,930 New	19,930 $1.28 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account